Compare CE & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CE | NVST |
|---|---|---|
| Founded | 1918 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.8B |
| IPO Year | 2004 | 2019 |
| Metric | CE | NVST |
|---|---|---|
| Price | $59.43 | $25.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $59.47 | $25.33 |
| AVG Volume (30 Days) | ★ 2.6M | 2.4M |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.23% | N/A |
| EPS Growth | 23.62 | ★ 104.31 |
| EPS | N/A | ★ 0.28 |
| Revenue | ★ $9,544,000,000.00 | $2,566,500,000.00 |
| Revenue This Year | $1.00 | $6.64 |
| Revenue Next Year | $3.31 | $3.55 |
| P/E Ratio | ★ N/A | $95.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.13 | $14.22 |
| 52 Week High | $61.94 | $30.42 |
| Indicator | CE | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 37.89 |
| Support Level | $37.64 | $19.29 |
| Resistance Level | $61.12 | $30.18 |
| Average True Range (ATR) | 3.34 | 0.93 |
| MACD | 0.21 | -0.58 |
| Stochastic Oscillator | 91.84 | 3.28 |
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.